| 发明名称 |
INTRANASAL NALTREXONE |
| 摘要 |
A stable transmucosal composition consisting essentially of naltrexone hydrochloride in water is provided. The composition is surprisingly stable at room temperature and can be used for simple, rapid and effective opioid overdose rescue. |
| 申请公布号 |
US2014171458(A1) |
申请公布日期 |
2014.06.19 |
| 申请号 |
US201314106257 |
申请日期 |
2013.12.13 |
| 申请人 |
3B Pharmaceuticals, Inc. |
发明人 |
Brown Darby C.;Montgomery Jason;Gertz Beau |
| 分类号 |
A61K31/485 |
主分类号 |
A61K31/485 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition consisting essentially of naltrexone hydrochloride and water, the composition capable of maintaining at least about 90% of said naltrexone hydrochloride in undegraded form after storage for 180 days at room temperature.
|
| 地址 |
Parker CO US |
